Evidence map›Paper›PMID 37291218›Full record

ArticleNature aging2023

Targeting lymphoid-derived IL-17 signaling to delay skin aging.

Paloma Solá, Elisabetta Mereu, Júlia Bonjoch, Marta Casado-Peláez, Neus Prats, Mònica Aguilera, Oscar Reina, Enrique Blanco, Manel Esteller, Luciano Di Croce and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nature aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Paloma Solá *Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0003-1554-0344
Elisabetta Mereu *Josep Carreras Leukemia Research Institute, Badalona, Spain.ORCID 0000-0001-6101-8472
Júlia Bonjoch *Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.
Marta Casado-Peláez *Josep Carreras Leukemia Research Institute, Badalona, Spain.ORCID 0000-0002-8428-8384
Neus PratsInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.
Mònica AguileraInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0003-0763-7947
Oscar ReinaInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.
Enrique BlancoCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0001-6261-7370
Manel EstellerJosep Carreras Leukemia Research Institute, Badalona, Spain.
Luciano Di CroceCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Holger HeynCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. holger.heyn@cnag.crg.eu.ORCID 0000-0002-3276-1889
Guiomar SolanasInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain. guiomar.solanas@irbbarcelona.org.ORCID 0000-0001-8388-8647
Salvador Aznar BenitahInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.ORCID 0000-0002-9059-5049
Institute for Research in Biomedicine · ESInstitució Catalana de Recerca i Estudis Avançats · ESCentre for Genomic Regulation · ESJosep Carreras Leukaemia Research Institute · ES

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 787041
6 · The paper itself

Abstract

Skin aging is characterized by structural and functional changes that contribute to age-associated frailty. This probably depends on synergy between alterations in the local niche and stem cell-intrinsic changes, underscored by proinflammatory microenvironments that drive pleotropic changes. The nature of these age-associated inflammatory cues, or how they affect tissue aging, is unknown. Based on single-cell RNA sequencing of the dermal compartment of mouse skin, we show a skew towards an IL-17-expressing phenotype of T helper cells, γδ T cells and innate lymphoid cells in aged skin. Importantly, in vivo blockade of IL-17 signaling during aging reduces the proinflammatory state of the skin, delaying the appearance of age-related traits. Mechanistically, aberrant IL-17 signals through NF-κB in epidermal cells to impair homeostatic functions while promoting an inflammatory state. Our results indicate that aged skin shows signs of chronic inflammation and that increased IL-17 signaling could be targeted to prevent age-associated skin ailments.

Indexed as

Interleukin-17Skin AgingAnimalsImmunity, InnateLymphocytesMiceSkinInterleukin-17

Identifiers

PMID37291218
PMCPMC10275755
OpenAlexW4379878884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.